Recordati reported EUR202.6M in Cost of Sales for its fiscal quarter ending in March of 2026.





Cost Of Sales Change Date
Almirall EUR 191.5M 2.29M Dec/2025
GlaxoSmithKline GBP 1.88B 736M Mar/2026
Hikma Pharmaceutical USD 959M 492.5M Dec/2025
Orion EUR 163.7M 22.9M Mar/2026
Sanofi EUR 3.67B 621M Mar/2026